Research map: Genotype–location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas

Back to the article

Papers in this map

  1. LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity · Christophe Nioche · 2018 · 1203 citations · Cited by this paper
  2. Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort · 2026 · Related
  3. Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional Activity · Magalie Rocheville · 2000 · 888 citations · Cited by this paper
  4. Whole-body TSPO-PET reveals stage-dependent disruption of systemic immune organ interactions in glioblastoma · 2026 · Related
  5. SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma · Éric Letouzé · 2013 · 795 citations · Cited by this paper
  6. Evaluation of treatment efficacy of the 161Tb- and 177Lu-Labeled GRPR antagonists AMTG and RM2 in a mouse model of prostate cancer · 2026 · Related
  7. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting · Jean Claude Reubi · 2003 · 592 citations · Cited by this paper
  8. From image reconstruction to clinical prognosis: A comprehensive analysis of centiloid-based amyloid PET assessment · 2026 · Related
  9. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity · Patricia L. M. Dahia · 2014 · 551 citations · Cited by this paper
  10. [18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice · 2026 · Related
  11. The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance · Leo J. Hofland · 2003 · 477 citations · Cited by this paper
  12. CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson’s disease · 2026 · Related
  13. A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET · Fanny Orlhac · 2018 · 407 citations · Cited by this paper
  14. Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy · 2026 · Related
  15. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma · David Taïeb · 2019 · 395 citations · Cited by this paper
  16. In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer’s disease continuum · 2026 · Related
  17. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB -Associated Metastatic Pheochromocytoma and Paraganglioma · Ingo Janssen · 2015 · 274 citations · Cited by this paper
  18. Prospective comparison of [68Ga]Ga-FAPI-04 PET/MRI, [18F]FDG PET/CT, and contrast-enhanced MRI for predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer · 2026 · Related
  19. Performance of 68Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis · Sangwon Han · 2018 · 203 citations · Cited by this paper
  20. 68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data · 2026 · Related
  21. 68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity · Chian A. Chang · 2016 · 197 citations · Cited by this paper
  22. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma · Alexandre Buffet · 2020 · 193 citations · Cited by this paper
  23. 68 Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI · Ingo Janssen · 2015 · 186 citations · Cited by this paper
  24. Somatostatin Receptor Subtypes in Human Pheochromocytoma: Subcellular Expression Pattern and Functional Relevance for Octreotide Scintigraphy · Jochen Mundschenk · 2003 · 141 citations · Cited by this paper
  25. False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease · Jay S Fonte · 2011 · 136 citations · Cited by this paper
  26. Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases · Aurélien Archier · 2015 · 128 citations · Cited by this paper
  27. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement · David Taïeb · 2023 · 98 citations · Cited by this paper
  28. Novel insights in somatostatin receptor physiology · Giovanni Tulipano · 2007 · 71 citations · Cited by this paper
  29. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas · Marianne Susan Elston · 2014 · 71 citations · Cited by this paper
  30. Selective agonism in somatostatin receptor signaling and regulation · Agnes Schönbrunn · 2007 · 56 citations · Cited by this paper
  31. Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses · Alessa Fischer · 2023 · 49 citations · Cited by this paper
  32. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68 Ga-DOTATATE, FDG, 18 F-FDOPA, and 18 F-FDA) · Abhishek Jha · 2021 · 32 citations · Cited by this paper
  33. Somatostatin Receptor–Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas · Yingjun Zhi · 2023 · 8 citations · Cited by this paper
  34. [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation · Miriam Pepponi · 2024 · 8 citations · Cited by this paper
  35. Adrenal tumour imaging: clinical, molecular, and radiomics perspectives · Karel Pacák · 2025 · 8 citations · Cited by this paper
  36. Outcomes of Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma · Gokce Belge Bilgin · 2025 · 2 citations · Cited by this paper
  37. [68Ga]Ga-DOTATATE uptake in pheochromocytoma/paraganglioma predicts SSTR2 expression by immunohistochemistry: Strongest uptake in head and neck paraganglioma · Alessa Fischer · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)